Discover how the MiSeq i100's breakthrough innovations translate into real-world benefits for your infectious disease surveillance and microbiology research. This webinar, designed for both experienced Next-Generation Sequencing (NGS) users and newcomers, will show you how the MiSeq i100 can optimize workflows, expand research capabilities, and provide a seamless entry into the world of genomics. Unlock new possibilities with MiSeq i100 and Illumina’s integrated Infectious disease and microbiology solutions.

In this webinar, you will:

• Experience the MiSeq i100 Advantage: Discover how its innovative features translate into tangible benefits for your work.
• Unlock a World of Solutions: Explore Illumina's comprehensive suite of workflow solutions designed to simplify your workflows and empower your research or public health investigation, including enhancing surveillance of public health threats and implement multiomics approaches for microbiology research.

Access the simplest, fastest benchtop sequencing system providing highly accurate data for microbiome insights, novel virus tracking, and more.

Cara Lim
Senior Infectious Disease and Microbiology Segment Manager,
Illumina Asia Pacific, Middle East & Africa (AMEA)

Dr Cara Lim is the Senior Infectious Disease & Microbiology Segment Manager at Illumina, where she champions the use of high-quality next-generation sequencing (NGS) data to advance precision public health, transform infectious disease management, and drive cutting-edge microbiology research. She leverages insights and collaborations from diverse economic settings to translate the promise of genomic sequencing into tangible improvements in human health, particularly in infectious disease and public health.